標題: 日股...製藥..Santen Pharmaceutical 参天製薬 (日股 4536,美股 SNPHY)
kaka
同學




UID 6717
精華 0
積分 0
帖子 6266
閱讀權限 99
註冊 2014-5-7
用戶註冊天數 3636
用戶失蹤天數 1742

111.83.18.104
分享 
發表於 2017-11-5 14:19  資料 私人訊息 
日股...製藥..Santen Pharmaceutical 参天製薬 (日股 4536,美股 SNPHY)
日股...製藥..Santen Pharmaceutical 参天製薬 (日股 4536,美股 SNPHY)


http://www.santen.co.jp


https://en.wikipedia.org/wiki/Santen_Pharmaceutical


Santen Pharmaceutical Co., Ltd. (参天製薬株式会社, Santen Seiyaku Kabushiki-gaisha), is Japanese pharmaceutical company, specializing in ophthalmology and rheumatology medicines. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.[3]


The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.[4] In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products.[5]


Business locationsSanten has 3 plants located in Hōdatsushimizu, Ishikawa, in Tampere and in Suzhou, 21 subsidiary companies located in Japan, the US, the Netherlands, Finland, United Kingdom & Ireland, Spain, Switzerland, Italy, France,[6] Germany, Sweden, China, South Korea, Taiwan, India, Thailand, Malaysia, the Philippines and Singapore. Its R&D center is located in Ikoma, Nara.[7][8]
頂部